CyberArk软件 CYBR 深 沪
等待开盘 11-03 09:30:00 美东时间
520.78
+4.310
+0.83%
华盛通- 最 高522.635
- 今 开518.76
- 成交量 47.30万股
- 最 低 513.97
- 昨 收 516.47
- 总市值 262.51亿
- 52周最高 526.19
- 市盈率 静 --
- 换手率 0.94%
- 52周最低 288.00
- 委 比 77.91%
- 总股本 5040.72万
- 历史最高 526.19
- 量 比 0.82
- 振 幅 1.68%
- 历史最低 22.12
- 每 手 1
- 风险率 60.08%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Is CyberArk Software Ltd Gaining or Losing Market Support?
CyberArk Software Ltd's (NYSE:CYBR) short interest as a percent of float has fa...
10-25 03:00
PQC Market Explodes: Quantum Threat Forces Urgent $2.84B Investment Surge
Equity Insider News Commentary Issued on behalf of Scope Technologies Corp. VANCOUVER, BC, Oct. 22, 2025 /PRNewswire/ -- Equity InsiderNews Commentary – Post-Quantum Cryptography (PQC) marke...
10-22 21:29
Salesforce leads enterprise software stocks higher as market climbs
Salesforce (NYSE:CRM) led enterprise software stocks higher on Monday as the major composites and indices increased across the board. Shares of Salesforce jumped 4.6% by the time the market closed. ...
10-21 04:01
Software sector appears ripe for beats as Q3 earnings arrive: Mizuho
As the earnings season arrives, Mizuho's industry checks show that the software sector as a whole should demonstrate better-than-expected growth during the third quarter. "Our 3Q checks were very soli...
10-19 20:00
美股大行评级 | 贝莱德、花旗、摩根大通、富国银行均获上调目标价！汇丰上调超微公司目标价升至310美元
今日重点评级关注：Roth Capital：维持Cingulate"买入"评级，目标价从10美元升至17美元；JMP证券：维持BioCryst Pharma"跑赢大市"评级，目标价从17美元升至27美元
10-16 10:43
美股大行评级 | 麦格理首予哔哩哔哩"跑赢大市"评级，目标价36.03美元； 高盛首予联合健康集团"买入"评级，目标价406美元
今日重点评级关注：摩根士丹利：上调Alvotech评级至"超配"，目标价14美元；蒙特利尔银行：维持PG&E"跑赢大市"评级，目标价从23美元升至25美元
10-15 18:20
AMD获上调评级，美光遭下调评级：华尔街顶级分析师最新评级报告
华尔街最受关注、且能影响市场走势的研究评级报告现已汇总于此。以下是由 The Fly 整理的、投资者需关注的今日最新评级动态。 五大评级上调案例： W...
10-14 22:20
This Micron Technology Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a comple...
10-14 19:39
Barclays Downgrades CyberArk Software to Equal-Weight, Raises Price Target to $520
Barclays analyst Saket Kalia downgrades CyberArk Software (NASDAQ:CYBR) from Overweight to Equal-Weight and raises the price target from $440 to $520.
10-14 19:04
